Natural Medicine Division 2026 Regulatory Agenda

CDOR Natural Medicine Division 2026 Regulatory Agenda

Natural Medicine Division 2026 Regulatory Agenda

Schedule 

Rule Number and Title
(or Description)

New rule,
revision,
or repeal?

Statutory or
other basis for
adoption of rule

Part of
Mandatory
Rule Review?

Purpose

Stakeholders

Anticipated
Hearing Date

Mar.1-CCR-213-1, Rule 2000 SeriesRevision44-50-104(2), 44-50-202(1)
(b),
44-50-203(1)(a), 44-50-203
(1)(c), 44-50-203(2)(a), 44-
50-601(2)-(3), and 44-50-
602, C.R.S.		 Licensing updatesNMD Stakeholder ListSpring 2026
Mar.1-CCR-213-1, Rule 2005Revision44-50-104(2), 44-50-202(1)
(b),
44-50-203(1)(a), 44-50-203
(1)(c), 44-50-203(2)(a), 44-
50-601(2)-(3), and 44-50-
602, C.R.S.

X

Annual required fee reviewNMD Stakeholder ListSpring 2026
Mar.1-CCR-213-1, Rule 2005New44-50-104(2), 44-50-202(1)
(b),
44-50-203(1)(a), 44-50-203
(1)(c), 44-50-203(2)(a), 44-
50-601(2)-(3), and 44-50-
602, C.R.S.		 Creation of Owner Entity feeNMD Stakeholder ListSpring 2026
Aug.1-CCR-213-1, Rule 3000 SeriesRevision44-50-202(1)(b), 44-50-203
(1)(b),
44-50-203(1)(g), 44-50-203
(1)(k), and 44-50-301(4), C.
R.S.		 Clarification of Transfer rulesNMD Stakeholder ListFall 2026
Aug.1-CCR-213-1, Rule 8000 SeriesRevision44-50-202(1)(b), 44-50-203
(1)(a),
44-50-203(1)(d), 44-50-203
(1)(g), 44-50-203(1)(l), 44-
50-203(2)(a), and 44-50-401,
C.R.S.		 Clarifying transfers, tracking and reporting
requirements for healing centers		NMD Stakeholder ListFall 2026
Aug.1-CCR-213-1, Rule 9040(G)Revision44-50-202(1)(b), 44-50-202
(1)(c),
44-50-202(1)(e), 44-50-203
(1)(a), 44-50-203(1)(b), 44-
50-203(2)(l), 44-50-203(2)
(n), and 44-50-203(2)(r),
24-4-104, 24-4-105, and 44-
50-701, C.R.S.		 Internal reference typoNMD Stakeholder ListFall 2026

Back to top

Return to CDOR 2025 Agenda and 2026 Report Page